Comparative analyses of the four known anthraquinone-fused enediynes biosynthetic gene clusters identified four genes, tnmE6, tnmH, tnmL, and tnmQ, unique to the tnm gene cluster. Larger scale fermentation of both the S. sp. CB03234 wild-type and the Δ tnmH and Δ tnmL mutant strains resulted in the characterization of 20 new tiancimycin (TNM) congeners, including five enediynes. These findings enabled a proposal for the late stage of TNM biosynthesis featuring an intermediate possibly common for all anthraquinone-fused enediynes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204227PMC
http://dx.doi.org/10.1021/acs.orglett.8b02584DOI Listing

Publication Analysis

Top Keywords

anthraquinone-fused enediynes
12
biosynthetic gene
8
gene clusters
8
tnmh tnml
8
comparative studies
4
studies biosynthetic
4
clusters anthraquinone-fused
4
enediynes
4
enediynes shedding
4
shedding light
4

Similar Publications

Dynemicin A Derivatives as Potential Cancer Chemotherapeutics by Mutasynthesis.

Helv Chim Acta

December 2023

Department of Chemistry, Remsen Hall, The Johns Hopkins University, 3400 North Charles St., Baltimore, MD 21218, USA.

The enediyne antitumor antibiotics have remarkable structures and exhibit potent DNA cleavage properties that have inspired continued interest as cancer therapeutics. Their complex structures and high reactivity, however, pose formidable challenges to their production and development in the clinic. We report here proof-of-concept studies using a mutasynthesis strategy to combine chemical synthesis of select modifications to a key iodoanthracene-γ-thiolactone intermediate in the biosynthesis of dynemicin A and all other known anthraquinone-fused enediynes (AFEs).

View Article and Find Full Text PDF
Article Synopsis
  • Anthraquinone-fused enediynes are natural compounds with anticancer properties that include a DNA-intercalating anthraquinone part, but the process of their biosynthesis isn't fully understood yet.
  • Recent research identified two key enzymes, DynE13 and DynA1, that work together to convert a precursor compound into hydroxyanthraquinone, with specific roles in adding oxygen and removing sulfur.
  • The study revealed that DynE13 adds two oxygen atoms while breaking down sulfur and carbon, while DynA1 adds the last oxygen atom, highlighting their essential roles in creating anthraquinones and providing insight into their biosynthetic mechanisms.
View Article and Find Full Text PDF

Background: Anthraquinone-fused enediynes (AFEs) are excellent payloads for antibody-drug conjugates (ADCs). The yields of AFEs in the original bacterial hosts are extremely low. Multiple traditional methods had been adopted to enhance the production of the AFEs.

View Article and Find Full Text PDF
Article Synopsis
  • Dynemicin A has been primarily studied since 1989 as an anthraquinone-fused enediyne (AFE), but new research focuses on the DNA interaction of other AFEs like tiancimycins and yangpumicins.
  • The study finds that these AFEs show strong cytotoxic effects on tumor cells, with tiancimycin A particularly effective in reducing breast tumor growth while causing minimal toxicity.
  • Molecular simulations suggest that tiancimycin A binds to DNA differently than dynemicin A, allowing it to precisely target certain DNA sequences, which could inform the design of new AFEs for cancer treatment.
View Article and Find Full Text PDF

Structural and functional studies of the carminomycin 4--methyltransferase DnrK are described, with an emphasis on interrogating the acceptor substrate scope of DnrK. Specifically, the evaluation of 100 structurally and functionally diverse natural products and natural product mimetics revealed an array of pharmacophores as productive DnrK substrates. Representative newly identified DnrK substrates from this study included anthracyclines, angucyclines, anthraquinone-fused enediynes, flavonoids, pyranonaphthoquinones, and polyketides.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!